Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „listed“
Suchtreffer
Begriffe & Kennungen
Abasaglar (previously Abasria) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbasaglar (previously Abasria) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · The following related adverse reactions from clinical trials are listed below as MedDRA preferred term by syst
Eintrag öffnenAbasaglar (previously Abasria) · 4.8 · The following related adverse reactions from clinical trials are listed below as MedDRA preferred term by syst
Eintrag öffnenAbilify Maintena · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify Maintena · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify Maintena · 4.8 · All ADRs are listed by system organ class and frequency; very common (≥ 1/10), common (≥ 1/100 to < 1/10), unc
Eintrag öffnenAbilify Maintena · 4.8 · All ADRs are listed by system organ class and frequency; very common (≥ 1/10), common (≥ 1/100 to < 1/10), unc
Eintrag öffnenAbilify Maintena · 4.8 · The ADRs listed under the frequency “not known” were reported during post-marketing use.
Eintrag öffnenAbilify Maintena · 4.8 · The ADRs listed under the frequency “not known” were reported during post-marketing use.
Eintrag öffnenAbiraterone Mylan · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Women who are
Eintrag öffnenAbiraterone Mylan · 4.8 · Adverse reactions observed during clinical studies and post-marketing experience are listed below by frequency
Eintrag öffnenAblymico · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAblymico · 4.8 · Table 4 lists adverse reactions reported in adults. Adverse reactions are listed by system organ class and fre
Eintrag öffnenAbraxane · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbrysvo · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenAbrysvo · 4.8 · Adverse reactions are listed according to the following frequency categories: Very common (≥1/10); Common (≥1/
Eintrag öffnenAbrysvo · 4.8 · Adverse reactions reported are listed per system organ class.
Eintrag öffnenAbseamed · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAclasta · 4.3 · - Hypersensitivity to the active substance, to any bisphosphonates or to any of the excipients listed in secti
Eintrag öffnen